title: The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6.
abstract: Adenosine is an endogenous metabolite produced during hypoxia or inflammation. Previously implicated as an anti-inflammatory mediator in CD4(+) T cell regulation, we report that adenosine acts via dendritic cell (DC) A(2B) adenosine receptor (A(2B)AR) to promote the development of Th17 cells. Mouse naive CD4(+) T cells cocultured with DCs in the presence of adenosine or the stable adenosine mimetic 5'-(N-ethylcarboximado) adenosine resulted in the differentiation of IL-17- and IL-22-secreting cells and elevation of mRNA that encode signature Th17-associated molecules, such as IL-23R and RORγt. The observed response was similar when DCs were generated from bone marrow or isolated from small intestine lamina propria. Experiments using adenosine receptor antagonists and cells from A(2B)AR(-/-) or A(2A)AR(-/-)/A(2B)AR(-/-) mice indicated that the DC A(2B)AR promoted the effect. IL-6, stimulated in a cAMP-independent manner, is an important mediator in this pathway. Hence, in addition to previously noted direct effects of adenosine receptors on regulatory T cell development and function, these data indicated that adenosine also acts indirectly to modulate CD4(+) T cell differentiation and suggested a mechanism for putative proinflammatory effects of A(2B)AR.
authors: Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
authors: Jeffrey M
authors: JM
authors: Wilson
authors: Courtney C
authors: CC
authors: Kurtz
authors: Steven G
authors: SG
authors: Black
authors: William G
authors: WG
authors: Ross
authors: Mohammed S
authors: MS
authors: Alam
authors: Joel
authors: J
authors: Linden
authors: Peter B
authors: PB
authors: Ernst
references: J Immunol. 2009 Apr 15;182(8):4616-23
references: 19342636
references: J Exp Med. 2007 Jun 11;204(6):1257-65
references: 17502665
references: Immunity. 2007 Oct;27(4):647-59
references: 17919941
references: Nat Immunol. 2007 Oct;8(10):1086-94
references: 17873879
references: Cell Res. 2010 Jan;20(1):4-12
references: 20010916
references: Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16788-93
references: 19805374
references: J Pharmacol Exp Ther. 2006 Apr;317(1):172-80
references: 16339914
references: Curr Opin Immunol. 2007 Dec;19(6):652-7
references: 17766098
references: Nat Rev Immunol. 2008 Nov;8(11):829-35
references: 18949018
references: J Immunol. 2010 Aug 15;185(4):1993-8
references: 20686167
references: J Immunol. 2006 Nov 15;177(10):6780-6
references: 17082591
references: Blood. 2003 May 15;101(10):3985-90
references: 12446452
references: Nat Immunol. 2005 Nov;6(11):1123-32
references: 16200070
references: Nat Immunol. 2009 Jun;10(6):603-9
references: 19448631
references: J Immunol. 2006 Sep 1;177(5):2765-9
references: 16920910
references: Cell Host Microbe. 2008 Oct 16;4(4):337-49
references: 18854238
references: Blood. 2008 Sep 1;112(5):1822-31
references: 18559975
references: Nat Immunol. 2005 Nov;6(11):1133-41
references: 16200068
references: J Biol Chem. 2007 Mar 30;282(13):9358-9363
references: 17277312
references: Gastroenterology. 2008 Sep;135(3):861-70
references: 18601927
references: Mol Pharmacol. 1999 Mar;55(3):614-24
references: 10051547
references: Blood. 1997 Aug 15;90(4):1600-10
references: 9269779
references: J Immunol. 1986 Apr 1;136(7):2348-57
references: 2419430
references: J Exp Med. 2006 Nov 27;203(12):2639-48
references: 17088433
references: Trends Immunol. 2004 Jan;25(1):33-9
references: 14698282
references: FASEB J. 2008 Oct;22(10):3491-9
references: 18625677
references: Expert Opin Ther Targets. 2009 Nov;13(11):1267-77
references: 19769545
references: Br J Pharmacol. 2008 Sep;155(1):127-37
references: 18536750
references: Curr Opin Immunol. 2007 Feb;19(1):55-62
references: 17137775
references: Nature. 2001 Dec 20-27;414(6866):916-20
references: 11780065
references: J Immunol. 2004 Apr 1;172(7):3983-8
references: 15034008
references: Trends Immunol. 2009 Jun;30(6):263-70
references: 19427267
references: Am J Physiol. 1999 Sep;277(3):F404-12
references: 10484524
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: J Immunol. 2009 Apr 15;182(8):4957-64
references: 19342675
references: J Clin Invest. 2006 Jul;116(7):1913-23
references: 16823489
references: Blood. 2007 Oct 1;110(7):2685-95
references: 17525287
references: J Immunol. 2008 Mar 15;180(6):4173-81
references: 18322229
references: Gut. 2008 Dec;57(12):1682-9
references: 18653729
references: Blood. 2008 Jan 1;111(1):251-9
references: 17909080
references: J Immunol. 2005 Jan 15;174(2):1073-80
references: 15634932
references: Annu Rev Immunol. 2004;22:657-82
references: 15032592
references: Immunity. 2009 Mar 20;30(3):372-83
references: 19285436
references: J Clin Invest. 2006 Aug;116(8):2173-2182
references: 16841096
references: Trends Immunol. 2005 Jun;26(6):299-304
references: 15922945
references: Immunol Cell Biol. 2010 Feb;88(2):165-71
references: 19841638